Literature DB >> 18424113

The implicit rules of evidence-based drug policy: a U.S. perspective.

Robert MacCoun1, Peter Reuter.   

Abstract

Mesh：

Year:  2008        PMID： 18424113     DOI： 10.1016/j.drugpo.2008.02.012

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN： 0955-3959


× No keyword cloud information.
  3 in total

1.  The use of knowledge translation and legal proceedings to support evidence-based drug policy in Canada: opportunities and ongoing challenges.

Authors:  Kora Debeck; Thomas Kerr
Journal:  Open Med       Date:  2010-09-21

2.  Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Authors:  Lucas Wiessing; Marica Ferri; Vendula Běláčková; Patrizia Carrieri; Samuel R Friedman; Cinta Folch; Kate Dolan; Brian Galvin; Peter Vickerman; Jeffrey V Lazarus; Viktor Mravčík; Mirjam Kretzschmar; Vana Sypsa; Ana Sarasa-Renedo; Anneli Uusküla; Dimitrios Paraskevis; Luis Mendão; Diana Rossi; Nadine van Gelder; Luke Mitcheson; Letizia Paoli; Cristina Diaz Gomez; Maitena Milhet; Nicoleta Dascalu; Jonathan Knight; Gordon Hay; Eleni Kalamara; Roland Simon; Catherine Comiskey; Carla Rossi; Paul Griffiths
Journal:  Harm Reduct J       Date:  2017-04-22

Review 3.  Worldwide legislative challenges related to psychoactive drugs.

Authors:  Carolina Negrei; Bianca Galateanu; Miriana Stan; Cristian Balalau; Mircea Lucian Bogdan Dumitru; Eren Ozcagli; Concettina Fenga; Leda Kovatsi; Domniki Fragou; Aristidis Tsatsakis
Journal:  Daru       Date:  2017-06-02       Impact factor: 3.117
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.